For: | Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol 2015; 7(20): 2274-2291 [PMID: PMC4568488 DOI: 10.4254/wjh.v7.i20.2274] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i20/2274.htm |
Number | Citing Articles |
1 |
Joseph Ralph Kallini, Ahmed Gabr, Riad Salem, Robert J. Lewandowski. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma. Advances in Therapy 2016; 33(5): 699 doi: 10.1007/s12325-016-0324-7
|
2 |
Pei-Chun Wu, Lun-Zhang Guo, Shan Yu, Ning Zeng, Yu-Cheng Liu, Jia Yu, Zhiming Zhang, Ke Lu, Liangyu Sun, Chunfei Wang, Yu-Han Chang, Yin-Lin Lu, Yu-Fang Shen, Sheng Tai, Yueh-Hsun Chuang, Ja-An Annie Ho, Kai-Wen Huang, Yao-Ming Wu, Tzu-Ming Liu. Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green. Biomedical Optics Express 2022; 13(4): 1995 doi: 10.1364/BOE.446749
|
3 |
Altan F. Ahmed, Naziya Samreen, Joseph R. Grajo, Ivan Zendejas, Chris L. Sistrom, Amy Collinsworth, Ashwini Esnakula, Jehan L. Shah, Roniel Cabrera, Brian S. Geller, Beau B. Toskich. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma. Abdominal Radiology 2018; 43(7): 1825 doi: 10.1007/s00261-017-1354-6
|
4 |
Alexios Kelekis, Dimitrios Filippiadis. Computed Tomography and Ultrasounds for the Follow-up of Hepatocellular Carcinoma Ablation: What You Need to Know. Diagnostics 2016; 6(1): 9 doi: 10.3390/diagnostics6010009
|
5 |
Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik. Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice. Journal of Liver Cancer 2023; 23(2): 350 doi: 10.17998/jlc.2023.08.10
|
6 |
Gianluca Cassese, Ho-Seong Han, Boram Lee, Hae Won Lee, Jai Young Cho. Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a retrospective analysis from a high-volume referral center. Surgical Endoscopy 2024; 38(11): 6324 doi: 10.1007/s00464-024-11091-4
|
7 |
Huiting Su, Bing Li, Lan Zheng, Haixia Wang, Liping Zhang. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma. Oncotarget 2016; 7(30): 48401 doi: 10.18632/oncotarget.10269
|
8 |
Anum Aslam, Richard Kinh Gian Do, Victoria Chernyak, Mishal Mendiratta-Lala. LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging Evidence. Current Hepatology Reports 2020; 19(4): 437 doi: 10.1007/s11901-020-00546-6
|
9 |
Elena De Mattia, Erika Cecchin, Jerry Polesel, Francesco Lupo, Claudio Tiribelli, Marina Crovatto, Angela Buonadonna, Giuseppe Toffoli. UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. Liver International 2017; 37(9): 1345 doi: 10.1111/liv.13411
|
10 |
Mishal Mendiratta-Lala, William R. Masch, Kimberly Shampain, Andrew Zhang, Alexandria S. Jo, Sarah Moorman, Anum Aslam, Katherine E. Maturen, Matthew S. Davenport. MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review. Radiology: Imaging Cancer 2020; 2(1): e190024 doi: 10.1148/rycan.2020190024
|
11 |
Yu Wang, Yingren Zhao, Xu Zhang, Aiyun Zhang, Juan Ma. RETRACTED: Long noncoding RNA LBX2-AS1 drives the progression of hepatocellular carcinoma by sponging microRNA-384 and thereby positively regulating IRS1 expression. Pathology - Research and Practice 2020; 216(4): 152903 doi: 10.1016/j.prp.2020.152903
|
12 |
Ran Xue, Qinghua Meng, Juan Li, Jiliang Feng, Hanping Shi. Worse or better?—Cirrhosis with hepatocellular carcinoma. Medical Hypotheses 2016; 97: 85 doi: 10.1016/j.mehy.2016.10.019
|
13 |
Jun He, Deng Xiang, Yanshui Lin. MicroRNA‑708 inhibits the proliferation and invasion of osteosarcoma cells by directly targeting ZEB1. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10013
|
14 |
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
|
15 |
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World Journal of Hepatology 2020; 12(10): 738-753 doi: 10.4254/wjh.v12.i10.738
|
16 |
Naik Vietti Violi, Jeffrey Gnerre, Amy Law, Stefanie Hectors, Octavia Bane, John Doucette, Ghadi Abboud, Edward Kim, Myron Schwartz, M Isabel Fiel, Bachir Taouli. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology. European Radiology 2022; 32(9): 6493 doi: 10.1007/s00330-022-08732-4
|
17 |
Eric A. Wang, Jeff P. Stein, Ross J. Bellavia, Scott R. Broadwell. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. International Journal of Clinical Practice 2017; 71(11): e12972 doi: 10.1111/ijcp.12972
|
18 |
Mark L. Lessne, Andrew Kesselman, Paul V. Suhocki. Radiology in Global Health. 2019; : 339 doi: 10.1007/978-3-319-98485-8_24
|
19 |
Guangtao Sun, Kejian Sun, Chao Shen. Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02246-x
|
20 |
Xiaoxi Fan, Jingjing Song, Zhongwei Zhao, Minjiang Chen, Jianfei Tu, Chenying Lu, Fazong Wu, Dengke Zhang, Qiaoyou Weng, Liyun Zheng, Min Xu, Jiansong Ji. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT. Cancer Letters 2019; 460: 119 doi: 10.1016/j.canlet.2019.06.008
|
21 |
Chiara Costa, Michele Teodoro, Carmela Alessandra Rugolo, Carmela Alibrando, Federica Giambò, Giusi Briguglio, Concettina Fenga. MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure. Toxicology Reports 2020; 7: 759 doi: 10.1016/j.toxrep.2020.05.003
|
22 |
Rony Kampalath, Karen Tran-Harding, Richard K.G. Do, Mishal Mendiratta-Lala, Vahid Yaghmai. Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 389 doi: 10.1016/j.mric.2021.05.013
|
23 |
Encheng Yang, Xiao Li, Ningyi Jin. The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0351-0
|
24 |
Dafina Nikolova, Meri Trajkovska, Emilija Nikolovska Trpcevska, Aleksandar Eftimov, Rubens Jovanovik, Vesna Janevska. Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations. Romanian Journal of Internal Medicine 2022; 60(3): 153 doi: 10.2478/rjim-2022-0006
|
25 |
Sheng Dong, Zusen Wang, Liqun Wu, Zhiqiang Qu. Effect of surgical margin in R0 hepatectomy on recurrence-free survival of patients with solitary hepatocellular carcinomas without macroscopic vascular invasion. Medicine 2016; 95(44): e5251 doi: 10.1097/MD.0000000000005251
|
26 |
Xiaoyu Wu, Liang Deng, Decai Tang, Gang Ying, Xuequan Yao, Fukun Liu, Gui Liang. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma. Tumor Biology 2016; 37(5): 6813 doi: 10.1007/s13277-015-4506-8
|
27 |
Lior Charach, Lior Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology. EMJ Hepatology 2017; : 75 doi: 10.33590/emjhepatol/10312421
|
28 |
Rida Fatima Saeed, Uzma Azeem Awan, Sidra Saeed, Sara Mumtaz, Nosheen Akhtar, Shaista Aslam. Therapeutic Approaches in Cancer Treatment. Cancer Treatment and Research 2023; 185: 177 doi: 10.1007/978-3-031-27156-4_10
|
29 |
Wei-Wei Ren, Dan-Dan Li, Xiaolan Chen, Xiao-Long Li, Ya-Ping He, Le-Hang Guo, Lin-Na Liu, Li-Ping Sun, Xiao-Ping Zhang. MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy. Cell Death & Disease 2018; 9(5) doi: 10.1038/s41419-018-0592-z
|
30 |
Khanh Nguyen, Kerri Jack, Weijing Sun. Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy. Diseases 2015; 4(1): 1 doi: 10.3390/diseases4010001
|
31 |
Xu Chao, Yong Jia, Xuesong Feng, Guoquan Wang, Xiaoping Wang, Hailong Shi, Fei Zhao, Chao Jiang. A Case–Control Study of ADCY9 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in the Chinese Han Population. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01450
|
32 |
Elena De Mattia, Erika Cecchin, Jerry Polesel, Alessia Bignucolo, Rossana Roncato, Francesco Lupo, Marina Crovatto, Angela Buonadonna, Claudio Tiribelli, Giuseppe Toffoli. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World Journal of Gastroenterology 2017; 23(36): 6674-6684 doi: 10.3748/wjg.v23.i36.6674
|
33 |
A. Bogdanovic, P. Bulajic, D. Masulovic, N. Bidzic, M. Zivanovic, D. Galun. Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83868-9
|
34 |
Hui Wang, Yuan Lv, Cao Wang, Dongjing Leng, Yan Yan, Moyondafoluwa Blessing Fasae, Syeda Madiha Zahra, Yanan Jiang, Zhiguo Wang, Baofeng Yang, Yunlong Bai. Systematic Analysis of Intestinal MicroRNAs Expression in HCC: Identification of Suitable Reference Genes in Fecal Samples. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00687
|
35 |
Shizhen Zhao, Honggang Wang. EVA1A Plays an Important Role by Regulating Autophagy in Physiological and Pathological Processes. International Journal of Molecular Sciences 2021; 22(12): 6181 doi: 10.3390/ijms22126181
|
36 |
Enrico Maria Fumarola, Anna Maria Ierardi, Pierpaolo Biondetti, Anna Paola Savoldi, Pasquale Grillo, Giovanna Gorga, Andrea Coppola, Gianpaolo Carrafiello. Follow-up of percutaneous microwave (MW) ablation of hepatic lesion: predictive value of CT at 24-h compared with CT at 1 month. Medical Oncology 2020; 37(5) doi: 10.1007/s12032-020-01364-y
|